Actinium Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Actinium Pharmaceuticals, Inc. has filed 494 SEC EDGAR filings since 05 Feb 2007

SEC filing history

Showing 1-5 of 5 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-82467

AMENDMENT NO. 4 TO SCHEDULE 13D

Filing date
05 Jul 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-82467

SC 13D/A filing

Filing date
21 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-82467

SC 13D/A filing

Filing date
23 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-82467

SCHEDULE 13D

Filing date
23 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-82467

SCHEDULE 13D

Filing date
18 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .